Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/126475
Title: Intraductal Delivery Of Adenoviruses Targets Pancreatic Tumors In Transgenic Ela-myc Mice And Orthotopic Xenografts
Author: Jose, A.
Sobrevals, L.
Camacho Sánchez, J. M.
Huch, Meritxell
Andreu, Nuria
Ayuso, E.
Navarro, P.
Alemany Bonastre, Ramon
Fillat i Fonts, Cristina
Keywords: Adenovirus
Tumors
Pàncrees
Adenoviruses
Tumors
Pancreas
Issue Date: 12-Jan-2013
Publisher: Impact Journals Llc
Abstract: Gene-based anticancer therapies delivered by adenoviruses are limited by the poor viral distribution into the tumor. In the current work we have explored the feasibility of targeting pancreatic tumors through a loco-regional route. We have taken advantage of the ductal network in the pancreas to retrogradelly inject adenoviruses through the common bile duct in two different mouse models of pancreatic carcinogenesis: The transgenic Ela-myc mice that develop mixed neoplasms displaying both acinar-like and duct-like neoplastic cells affecting the whole pancreas; and mice bearing PANC-1 and BxPC-3 orthotopic xenografts that constitute a model of localized human neoplastic tumors. We studied tumor targeting and the anticancer effects of newly thymidine kinase-engineered adenoviruses both in vitro and in vivo, and conducted comparative studies between intraductal or intravenous administration. Our data indicate that the intraductal delivery of adenovirus efficiently targets pancreatic tumors in the two mouse models. The in vivo application of AduPARTK(T) plus ganciclovir (GCV) treatment induced tumor regression in Ela-myc mice. Moreover, the intraductal injection of ICOVIR15-TKT oncolytic adenoviruses significantly improved mean survival of mice bearing PANC-1 and BxPC-3 pancreatic xenografts from 30 to 52 days and from 20 to 68 days respectively (p<0.0001) when combined with GCV. Of notice, both AduPARTK(T) and ICOVIR15-TKT antitumoral responses were stronger by ductal viral application than intravenously, in line with the 38-fold increase in pancreas transduction observed upon ductal administration. In summary our data show that cytotoxic adenoviruses retrogradelly injected to the pancreas can be a feasible approach to treat localized pancreatic tumors.
Note: Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.795
It is part of: Oncotarget, 2013, Vol. 4, Issue 1, P. 94-105
URI: http://hdl.handle.net/2445/126475
Related resource: https://doi.org/10.18632/oncotarget.795
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
JoseA.pdf4.06 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons